These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 3404696)
1. [Regression and therapy of atherosclerosis: regression of atherosclerosis under anti-cholesterol therapy]. Yamamoto A Nihon Rinsho; 1988 Mar; 46(3):686-93. PubMed ID: 3404696 [No Abstract] [Full Text] [Related]
2. [Regression and therapy of atherosclerosis: drug therapy of atherosclerosis viewed from serum lipoprotein analysis--reality of application, choice and administration of anticholesteremic agents]. Nakamura H Nihon Rinsho; 1988 Mar; 46(3):710-6. PubMed ID: 3404699 [No Abstract] [Full Text] [Related]
3. Evaluation of serum cholesterol reduction and xanthine oxidase inhibition in the treatment of atherosclerosis. Oster KA Recent Adv Stud Cardiac Struct Metab; 1973; 3():73-80. PubMed ID: 4808357 [No Abstract] [Full Text] [Related]
4. [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis]. Kalenich OS; Tertov VV; Liakishev AA; Ruda MIa; Orekhov AN Ter Arkh; 1991; 63(9):59-61. PubMed ID: 1759226 [TBL] [Abstract][Full Text] [Related]
13. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629 [TBL] [Abstract][Full Text] [Related]
14. [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis]. Takahashi T; Hiasa Y; Harada S; Hosokawa S; Kato S; Tanimoto M; Kishi K; Ohtani R J Cardiol; 1997 Aug; 30(2):67-72. PubMed ID: 9300286 [TBL] [Abstract][Full Text] [Related]
15. [Is regression of atherosclerosis possible?]. Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545 [TBL] [Abstract][Full Text] [Related]
16. Phospholipids in experimental atherosclerosis. Altman RF; de Mendonça JM; Schaeffer GM; de Souza JR; Bandoli JG; da Silva DJ; Lopes CR Arzneimittelforschung; 1974 Jan; 24(1):11-6. PubMed ID: 4406098 [No Abstract] [Full Text] [Related]
17. [Influence of prolonged statin therapy on the arterial distensibility in stable ischemic heart disease]. Kurpesa M; Tymiński M; Trzos E; Kidawa M; Krzemińska-Pakuła M Przegl Lek; 2005; 62(4):210-3. PubMed ID: 16229236 [TBL] [Abstract][Full Text] [Related]
18. [Large scale treatment? Limited knowledge about cholesterol and arteriosclerosis]. Berglund G Lakartidningen; 1991 May; 88(19):1762, 1764-5, 1767. PubMed ID: 2041423 [No Abstract] [Full Text] [Related]
19. [LDL lowering--level and time. Maybe two equally important parameters for protection against arteriosclerosis]. Herlitz J Lakartidningen; 2006 Oct 25-31; 103(43):3272-3. PubMed ID: 17117658 [No Abstract] [Full Text] [Related]
20. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]